DOI: 10.1001/jamahealthforum.2024.5015 ISSN: 2689-0186
Marketing and Safety Concerns for Compounded GLP-1 Receptor Agonists
T. Joseph Mattingly, Rena M. ContiThis Viewpoint discusses supply and demand for glucagon-like peptide 1 (GLP-1) receptor agonists and concerns with using compounded drugs to fill this demand.